Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs HCA Health Inc (HCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs HCA Health Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.58, while HCA Health Inc trades at $389.24 (market cap $84.04B). The key difference: HCA Health Inc pays a 0.82% dividend while iShares JPMorgan USD Emerging Markets Bond ETF pays none, and iShares JPMorgan USD Emerging Markets Bond ETF is trading nearer its 52-week high, HCA Health Inc nearer its low. Which is the better fit depends on your goals.
| EMB | HCA | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $97.74 | $545.13 |
52-Week Low | $91.59 | $334.32 |
Market Cap | — | $84.04B |
Enterprise Value | — | $132.95B |
Dividend Yield | — | 0.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EMB trades at $95.54, down slightly by 0.03% on the day, with a bearish technical signal driven by moving averages. Recent corporate actions include scheduled dividends for 2026, with payouts of $0.41 and $0.40 per share. News highlights focus on emerging market bond risks and Federal Reserve policy impacts, with the ETF showing a 12% total return over the past year but only 1% year-to-date gains as of May 2026.
The outlook for EMB is cautious due to bearish technical indicators and macroeconomic sensitivities. Key risks include emerging market sovereign default exposure and interest rate volatility. Analyst sentiment is mixed, with attention on Fed policy and global bond market dynamics as critical drivers for future performance.
HCA Healthcare (HCA) is trading at $363.60, down 6.95% amid lowered 2026 guidance. The stock shows bearish technical signals but maintains strong fundamentals with consistent revenue growth to $75.6 billion in 2025 and earnings beats in recent quarters. Analyst consensus remains bullish with a $469.40 price target despite recent negative sentiment from payer mix challenges.
The outlook presents a value opportunity given attractive valuation multiples (P/E 13.05, EV/EBITDA 8.48) and dividend yield, though risks include rising uninsured patients and margin compression. Long-term growth drivers include capacity expansion and specialty care investments, but near-term volatility may persist until Q2 earnings clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →
